BEGIN:VCALENDAR
PRODID:-//AddEvent Inc//AddEvent.com v1.7//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
DTSTART:19691231T170000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Join National Jewish Health for a complimentary CME breakfast at CHEST 2026. Register at NJHealth.org/ILDTreatment http://NJHealth.org/ILDTreatment\n\nFibrosing interstitial lung disease (ILD) presents complex challenges in recognizing progression\, selecting appropriate treatment\, and coordinating multidisciplinary care. In this interactive CME breakfast symposium\, experts in pulmonology\, rheumatology\, and radiology will use practical\, case-based discussion to examine evolving approaches to the assessment and management of fibrosing ILD.\n\nUsing HRCT findings and multidisciplinary perspectives\, faculty will explore how to recognize progressive pulmonary fibrosis\, identify clinical factors that may warrant treatment initiation or reassessment\, integrate immunomodulatory and antifibrotic approaches when appropriate\, and evaluate new and emerging evidence in the context of individualized patient care. Attendees will gain practical strategies for navigating complex treatment decisions and improving longitudinal management of patients with fibrosing ILD.\n\n1.0 CME/MOC\n\nFaculty:\nMelissa Griffith\, MD\, RhMSUS\nUniversity of Colorado School of Medicine\n\nDavid A. Lynch\, MB BCh\nNational Jewish Health\n\nJoshua J. Solomon\, MD\nNational Jewish Health
X-ALT-DESC;FMTTYPE=text/html:<strong>Join National Jewish Health for a complimentary CME breakfast at CHEST 2026. Register at </strong><a href="http://NJHealth.org/ILDTreatment" target="_blank" rel="noopener noreferrer"><strong>NJHealth.org/ILDTreatment</strong></a><br><br>Fibrosing interstitial lung disease (ILD) presents complex challenges in recognizing progression, selecting appropriate treatment, and coordinating multidisciplinary care. In this interactive CME breakfast symposium, experts in pulmonology, rheumatology, and radiology will use practical, case-based discussion to examine evolving approaches to the assessment and management of fibrosing ILD.<br><br>Using HRCT findings and multidisciplinary perspectives, faculty will explore how to recognize progressive pulmonary fibrosis, identify clinical factors that may warrant treatment initiation or reassessment, integrate immunomodulatory and antifibrotic approaches when appropriate, and evaluate new and emerging evidence in the context of individualized patient care. Attendees will gain practical strategies for navigating complex treatment decisions and improving longitudinal management of patients with fibrosing ILD.<br><br>1.0 CME/MOC<br><br>Faculty:<br />Melissa Griffith, MD, RhMSUS<br />University of Colorado School of Medicine<br><br>David A. Lynch, MB BCh<br />National Jewish Health<br><br>Joshua J. Solomon, MD<br />National Jewish Health
UID:0fd3d8d1104b48a6bde51cc897098d74addeventcom
SUMMARY:Navigating the Evolving Treatment Landscape in Fibrosing ILD: A Multidisciplinary Case-Based Approach
DTSTART;TZID=America/Phoenix:20261020T063000
DTEND;TZID=America/Phoenix:20261020T073000
DTSTAMP:20260926T224821Z
TRANSP:OPAQUE
STATUS:CONFIRMED
SEQUENCE:0
LOCATION:Sheraton Phoenix Downtown \nPhoenix Ballroom D&E\n340 N 3rd St\, Phoenix\, 85004\, AZ\, USA
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
BEGIN:VALARM
TRIGGER:-PT60M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR